ketotifen has been researched along with Pharyngitis in 1 studies
Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.
Pharyngitis: Inflammation of the throat (PHARYNX).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The clinical efficacy of a vilozen and ketotifen (zaditen) combination in the treatment of streptococcal infections along with the routine therapy was studied." | 9.07 | [Use of vilozen and ketotifen combination for increasing the effectiveness and prevention of complications of antibiotic therapy of streptococcal infections]. ( Frolov, VM; Peresadin, NA; Pustovoĭ, IuG, 1992) |
| "The clinical efficacy of a vilozen and ketotifen (zaditen) combination in the treatment of streptococcal infections along with the routine therapy was studied." | 5.07 | [Use of vilozen and ketotifen combination for increasing the effectiveness and prevention of complications of antibiotic therapy of streptococcal infections]. ( Frolov, VM; Peresadin, NA; Pustovoĭ, IuG, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frolov, VM | 1 |
| Peresadin, NA | 1 |
| Pustovoĭ, IuG | 1 |
1 trial available for ketotifen and Pharyngitis
| Article | Year |
|---|---|
[Use of vilozen and ketotifen combination for increasing the effectiveness and prevention of complications of antibiotic therapy of streptococcal infections].
Topics: Adjuvants, Immunologic; Drug Hypersensitivity; Erysipelas; Humans; Immunosuppressive Agents; Ketotif | 1992 |